SCHEMBL29368604

SCHEMBL29368604

COC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc(Br)cc1C(=O)c1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 5/20 0.45
HDAC4 P56524 4/20 0.39
HDAC1 Q13547 4/20 0.39
CTSS P25774 4/20 0.39
CTSK P43235 4/20 0.39
CTSB P07858 1/20 0.39
EGFR P00533 1/20 0.39
HDAC8 Q9BY41 3/20 0.38
HDAC3 O15379 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
SIRT5 Q9NXA8 1/20 0.36
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20680744 1.00 AAK1 (0.45) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL17244394 1.00 AAK1 (0.45) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL23327048 0.92 AAK1 (0.46) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL17244396 0.92 AAK1 (0.46) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL22853706 0.91 HDAC1 (0.41) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL20473233 0.90 CCR9 (0.45) HDAC4HDAC1CTSSCTSKHDAC8
SCHEMBL19006591 0.90 CCR9 (0.45) HDAC4HDAC1CTSSCTSKHDAC8
SCHEMBL29042814 0.88 AAK1 (0.44) AAK1HDAC4HDAC1CTSSCTSK
SCHEMBL20680144 0.88 HDAC1 (0.47) AAK1HDAC4HDAC1CTSSHDAC2
SCHEMBL20680143 0.88 HDAC1 (0.47) AAK1HDAC4HDAC1CTSSHDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116102558-A Novel benzodiazepine compound, preparation method and application thereof 中国药科大学 2023-05-12 CN disclosed
US-11236064-B2 Method for preparing 3-[(3S)-7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-[1,4]-benzodiazepin-3-yl] propionic acid methyl ester, and compounds useful in that method MOEHS IBERICA S.L. (ES) 2022-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236064-B2 Method for preparing 3-[(3S)-7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-[1,4]-benzodiazepin-3-yl] propionic acid methyl ester, and compounds useful in that method GABRA3, GRIK5, GABRA6 AAK1 2219/4885HDAC4 1944/4885HDAC1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.